DVL3: A Promising Drug Target / Biomarker (G1857)

Target Name: DVL3

NCBI ID: G1857

DVL3: A Promising Drug Target / Biomarker

Dopamine (D2) receptors are a family of transmembrane ion channels that play a crucial role in neural signaling. D2 receptors are involved in a wide range of physiological processes, including motor coordination, mood regulation, and pain perception. Despite the importance of D2 receptors, there is a growing interest in the research of DVL3, a protein that has been shown to interact with D2 receptors. In this article, we will explore the biology of DVL3 and its potential as a drug target.

Structure and Function

DVL3 is a protein that was discovered in 2004 as a gene candidate for a neurotransmitter receptor, D2. The DVL3 gene encodes a protein that consists of a N-terminus, a D1 domain, a D2 domain, and a C-terminus. The D1 and D2 domains are responsible for the protein's interaction with the D2 receptor, while the N-terminus and C-terminus are involved in its stability and cytoplasmic localization.

The D2 receptor is a G protein-coupled receptor (GPCR), which means that it is a transmembrane protein that consists of a extracellular portion, a transmembrane region, and an intracellular portion. The D2 receptor is involved in the regulation of various physiological processes, including sensory perception, neurotransmitter signaling, and behavioral state.

DVL3 Interaction with D2 Receptors

DVL3 has been shown to interact with the D2 receptor in a number of ways. First, DVL3 has been shown to block the activation of D2 receptors by dopamine. This interaction between DVL3 and D2 receptors is important for the regulation of D2 receptor function, as it allows for the regulation of sensory perception, neurotransmitter signaling, and behavioral state.

Second, DVL3 has been shown to modulate the stability of D2 receptors. This interaction between DVL3 and D2 receptors is important for the regulation of receptor stability, as it allows for the regulation of sensory perception, neurotransmitter signaling, and behavioral state.

Third, DVL3 has been shown to play a role in the regulation of cellular processes, including cell signaling, cell migration, and cell survival. This interaction between DVL3 and D2 receptors is important for the regulation of cellular processes, as it allows for the regulation of sensory perception, neurotransmitter signaling, and behavioral state.

DVL3 as a Drug Target

DVL3 has the potential to be a drug target due to its interaction with the D2 receptor. Because DVL3 has been shown to play a role in the regulation of D2 receptor function, it is a potential target for the development of new therapies for a variety of neurological and psychiatric disorders.

One potential approach to targeting DVL3 is to use small molecules that can modulate its activity. For example, drugs that can inhibit the interaction between DVL3 and D2 receptors could be developed to treat disorders that are characterized by hyperactive D2 receptors, such as addiction and schizophrenia.

Another potential approach to targeting DVL3 is to use antibodies that can selectively bind to it. This approach could be useful for treating disorders that are characterized by misfolded or misregulated DVL3, such as neurodegenerative diseases.

Conclusion

In conclusion, DVL3 is a protein that has been shown to interact with the D2 receptor, a GPCR that is involved in the regulation of various physiological processes. Despite its potential as a drug target, more research is needed to fully understand its biology and to develop effective therapies.

Protein Name: Dishevelled Segment Polarity Protein 3

Functions: Involved in the signal transduction pathway mediated by multiple Wnt genes

More Common Targets